Dr. Sheng's research focuses on addressing the needs of breast cancer patients, especially improving quality of life and addressing comorbidity, promptly detecting sequela of endocrine therapy, determining the optimal population for and timing of survivorship care and furthering obesity management in breast cancer patients.
Sheng JY, Blackford AL, Bardia A, Venkat R, Rosson G, Giles J, Hayes DF, Jeter SC, Zhang Z, Hayden J, Nguyen A, Storniolo AM, Tarpinian K, Henry NL, Stearns V. Prospective evaluation of finger two-point discrimination and carpal tunnel syndrome among women with breast cancer receiving adjuvant aromatase inhibitor therapy. Breast Cancer Res Treat. 2019 Aug; 176(3): 617-624. PMCID: PMC7082853
Sheng JY, Santa-Maria CA, Mangini N, Norman H, Couzi R, Nunes R, Wilkinson M, Visvanathan K, Connolly RM, Roussos-Torres ET, Fetting JH, Armstrong DK, Tao JJ, Jacobs L, Wright JL, Thorner ED, Hodgdon C, Horn S, Wolff AC, Stearns V, and Smith KL. Management of Breast Cancer During the COVID-19 Pandemic: A Stage- and Subtype-Specific Approach. JCO Oncology Practice. 2020 Oct; 16 (10): 665-674. PMCID: PMC7564133
Sheng JY, Blackford AL, Lim D, Carpenter A, Snyder CF. The impact of weight loss on physical function and symptoms in overweight or obese breast Cancer survivors: results from POWER-remote. J Cancer Survivorship. 2021 May 20; 10.1007. PMCID: PMC8605026
Sheng JY, Skuli SJ, Bantug ET, Zafman N, Riley C, Ruck JM, Smith KC, Snyder CF, Smith KL, Stearns V, Wolff AC. Late effects in in a high-risk population of breast cancer survivors. Supportive Care in Cancer. 2021 Feb; 30(2): 1749-1757. PMCID: PMC8732297
Goyal A, Milner GE, Cimino-Mathews A, Visvanathan K, Wolff AC, Sharma D, Sheng JY. Weight gain after hormone receptor-positive breast cancer. Current Oncology. 2022 June 6; 29 (6): 4090-4103. PMCID: PMC9222132